From: In vitro evaluation of defined oligosaccharide fractions in an equine model of inflammation
 | TNF- α (pg/ml) |  |  | IL-10 (pg/ml) |  |  |
---|---|---|---|---|---|---|
Incubation | Point estimate | Lower bound | Upper bound | Point estimate | Lower bound | Upper bound |
LPS 1 μg/ml | 1749.4 | 1495.2 | 2050.8 | 278.1 | 236.0 | 328.7 |
LPS + GOS 0.5% | 3655.5 * | 3115.0 | 4285.5 | 293.8 | 248.4 | 347.6 |
LPS + GOS 1.0% | 4989.0 * # | 4251.4 | 5843.0 | 268.8 | 227.5 | 316.7 |
LPS + GOS 2.0% | 7754.3 * # | 6607.8 | 9090.6 | 265.6 | 225.0 | 313.6 |
LPS + GOS/FOS 0.5% | 3601.1 * | 3074.8 | 4221.7 | 344.1 | 290.9 | 407.5 |
LPS + GOS/FOS 1.0% | 5530.3 * # | 4712.6 | 6483.4 | 307.4 | 260.6 | 362.9 |
LPS + GOS/FOS 2.0% | 6721.1 * | 5733.0 | 7879.3 | 264.0 | 223.9 | 311.7 |
LPS + GOS/FOS/AOS 0.5% | 4242.9 * | 3608.3 | 4969.1 | 374.3 * | 317.0 | 442.3 |
LPS + GOS/FOS/AOS 1.0% | 3317.6 * # | 2832.7 | 3893.3 | 269.6 # | 227.9 | 318.3 |
LPS + GOS/FOS/AOS 2.0% | 1029.7 * # | 874.8 | 1205.9 | 180.7 * # | 149.0 | 216.6 |